MDxHealth (MDXH) Shares Outstanding (Weighted Average) (2020 - 2025)
MDxHealth (MDXH) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $51.4 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 3.77% to $51.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.4 million through Dec 2025, up 3.77% year-over-year, with the annual reading at $51.4 million for FY2025, 3.77% up from the prior year.
- Shares Outstanding (Weighted Average) hit $51.4 million in Q4 2025 for MDxHealth, up from $49.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $51.4 million in Q4 2025 to a low of $15.6 million in Q4 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $32.0 million across 5 years, with a median of $27.3 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): soared 81.39% in 2024 and later rose 3.77% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $15.6 million in 2021, then grew by 4.43% to $16.3 million in 2022, then soared by 67.53% to $27.3 million in 2023, then skyrocketed by 81.39% to $49.5 million in 2024, then rose by 3.77% to $51.4 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for MDXH at $51.4 million in Q4 2025, $49.5 million in Q4 2024, and $27.3 million in Q4 2023.